Clinical trials referenced in this document:
Documents that mention this clinical trial
Daily self-reported and automatically generated smartphone-based sleep measurements in patients with newly diagnosed bipolar disorder, unaffected first-degree relatives and healthy control individuals
Prevalences of comorbid anxiety disorder and daily smartphone-based self-reported anxiety in patients with newly diagnosed bipolar disorder
Smartphone-based activity measurements in patients with newly diagnosed bipolar disorder, unaffected relatives and control individuals
Funding for this research was provided by:
Mental health services, Capital Region of Denmark
Sundhed og Sygdom, Det Frie Forskningsråd (DFF – 4183-00570)
Copenhagen Center for Health Technology
Augustinus Fonden (16-0083)
Received: 23 March 2020
Accepted: 23 July 2020
First Online: 2 November 2020
Ethical approval and consent to participate
: The Bipolar Illness Onset (BIO) study has been approved by the ethics committee in the Capital Region, Copenhagen, Denmark (ref. nr. H-7–2014-007) and the Danish Data Protection Agency, Capital Region of Copenhagen (protocol no.: RHP-2015–023). The study was conducted in accordance with the Declaration of Helsinki and all participants provided written informed consent.
: Not applicable.
: SS, SM, JB, and MFJ declare no competing interests. LVK and MV have within recent three years been a consultant for Lundbeck. JEB, MF are co-founders and shareholders of Monsenso ApS.